Jonathan Li

Jonathan Li has a diverse and extensive work experience spanning over several companies and roles. Jonathan is currently working as a Principal Scientist at Alamar Biosciences, Inc. since February 2022. Prior to that, they worked at Elanco as a Senior Principal Scientist/Senior Director from June 2021 to February 2022.

From 2014 to 2021, Jonathan worked at Kindred Biosciences, where they held various positions including Senior Principal Scientist, Principal Scientist, and Senior Scientist. Jonathan'sresponsibilities included conducting research for novel therapeutic proteins and new target discovery, leading molecular and cell biology groups, and overseeing recombinant therapeutic protein production.

Before joining Kindred Biosciences, Jonathan worked at Aragen Bioscience as a Senior Scientist in 2013, where they conducted molecular cloning experiments and communicated with multiple clients.

Jonathan's earlier work experience includes roles as a Senior Scientist at Intrexon from 2011 to 2013, where they designed cloning strategies and constructed expression vectors for recombinant antibodies and therapeutic proteins. Jonathan also worked as a Senior Scientist at Exelixis from 2006 to 2011, overseeing genotyping experiments and managing cloning, sequencing, and plasmid construction.

Jonathan started their career as a Staff Scientist at Celera Genomics from 2001 to 2006, where they were responsible for new target discovery, protein expression/purification, and technology development. Prior to that, they served as an Instructor/Research Scientist at the University of Chicago/Yale University from 1995 to 2001, where they discovered and characterized yeast ubiquitin-like proteases. Jonathan also worked as a Post-Doctoral Researcher at Yale University from 1992 to 1995, studying mouse interferon inducible genes.

Jonathan's early research experience includes their PhD research at the University of Illinois at Urbana-Champaign from 1986 to 1992, where they cloned and characterized genes involved in fatty acid biosynthesis.

Overall, Jonathan Li has a rich and extensive background in scientific research and leadership roles in the biotechnology industry, contributing to various aspects of therapeutic protein production, cloning, and target discovery.

Jonathan Li has a PhD from the University of Illinois Urbana-Champaign. Jonathan also worked as an instructor at the University of Chicago and completed a post-doc at Yale University. The specific field of study for each of these experiences is not provided.